Non-US issuers of securities with unsponsored ADRs in US capital markets may have gained a new defense strategy, a federal court in Los...
A Fresh Take
Insights on US legal developments
On Tuesday, January 18, 2022, the United States Federal Trade Commission (FTC) and Department of Justice Antitrust Division (DOJ)...
On January 20, 2022 the Federal Reserve Board published a paper that it described as the first step in a public discussion between the...
This article was originally published in STAT on January 18, 2022. I have been negotiating with representatives of the federal government...
We’re pleased to announce Freshfields’ 2021 De-SPAC Debrief: A comprehensive review of all de-SPAC transactions that closed in 2021. 2021...
Amid active anti-corruption efforts by US and foreign authorities in recent years, the Biden administration emphasized during 2021 that...
In Parts 1, 2 and 3 we covered some easy traps to fall into when trying to execute a distressed financing transaction but we can’t stop...
Partner and co-head of US Corporate and M&A Ethan Klingsberg recently appeared on Bloomberg Markets: The Close to discuss what he sees as...
Qualifying investors from a list of “Excepted Foreign States” (colloquially referred to as the “whitelist”) enjoy certain privileges...
The COVID-19 pandemic has accelerated the transformation of business models in the life sciences industry, with digital initiatives...
As the 2022 pipeline continues to flow, here’s a quick preview of where the tensions, action and hot spots will be in M&A this year,...
In a much-anticipated decision, the Delaware Court of Chancery issued its first opinion involving shareholder challenges to de-SPAC...